🇺🇸 FDA
Patent

US 10786495

Vesicular monoamine transporter 2 inhibitors for treating stuttering

granted A61KA61K31/4745A61P

Quick answer

US patent 10786495 (Vesicular monoamine transporter 2 inhibitors for treating stuttering) held by The Regents of the University of California expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/4745, A61P, A61P25/00